Skip to content

Study of Diagnosis of Color Power Doppler Combined Minimally Invasive Sampling for Endometrial Diseases

Study of Diagnosis of Color Power Doppler Combined Minimally Invasive Sampling for Endometrial Diseases

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03289468
Enrollment
200
Registered
2017-09-21
Start date
2017-07-10
Completion date
2019-12-30
Last updated
2019-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrial Diseases

Brief summary

The postmenopausal women with vaginal bleeding were selected in this cross-sectional study. The basic characteristics information and endometrial blood flow energy index of endometrium were detected by color power Doppler ultrasound, and the energy histogram of endometrium was obtained. The specimen of uterine cytology and endometrial tissue were obtained through minimally invasive endometrium sampler, which were diagnosed by pathology. The statistical data were used to detect endometrial and precancerous lesions to observe the endpoint, and to provide the energy histogram model of the early warning endothelial diseases.

Detailed description

The postmenopausal women with vaginal bleeding are selected in this cross-sectional study. The uterine bleeding in patients with blood system diseases, reproductive organ outside the uterus, other organs cancer metastasis to the uterus are excluded. The objects are divided into two groups(patients with endometrial benign diseases and patients with endometrial cancer and precancerous diseases) according to endometrial cytological and histological pathology. The endometrial thickness, basic characteristics information and endometrial blood flow energy index, endometrial vascularization index, blood flow index are detected by color power Doppler and the energy histogram of endometrium is obtained using a Voluson E8 (GE Medical Systems, USA) ultrasound system. Moreover,The specimen of uterine cytology and endometrial tissue are obtained through minimally invasive endometrium sampler, which were diagnosed by pathology.

Interventions

DIAGNOSTIC_TESTVoluson E8 (GE Medical Systems, USA), Minimally Invasive Endometrium Sampler

The endometrial thickness, basic characteristics information and endometrial blood flow energy index, endometrial vascularization index, blood flow index are detected by color power Doppler and the energy histogram of endometrium is obtained using a Voluson E8 (GE Medical Systems, USA) ultrasound system. The specimen of uterine cytology and endometrial tissue are obtained through minimally invasive endometrium sampler, which are diagnosed by pathology.

Sponsors

First Affiliated Hospital Xi'an Jiaotong University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
45 Years to 80 Years

Inclusion criteria

* Postmenopausal women with vaginal bleeding

Exclusion criteria

* Vaginal bleeding caused by hematological system diseases or genitals outside the uterus * Uterine bleeding caused by other organ cancers metastasize to the uterus

Design outcomes

Primary

MeasureTime frameDescription
The endometrial vascularization indexFrom March 2019 to December 2019The endometrial vascularization index include vascularization index(VI), flow index (FI) and vascularization flow index (VFI).

Secondary

MeasureTime frameDescription
The ultrasonography of endometriumFrom March 2019 to December 2019The ultrasonography of endometrium included shape, boundary and echo.
The endometrial thicknessFrom March 2019 to December 2019The endometrial thickness in centimeter.
The blood flow index of endometriumFrom March 2019 to December 2019The blood flow index include peak systolic velocity(PSV),cm/s, end diastolic velocity(EDV) ,cm/s, mean flow velocity(MnV) ,cm/s, pulsatility index(PI), resistance index(RI).

Countries

China

Contacts

Primary ContactXiaofeng YANG, Doctor
yxf73@163.com0086-18602900810

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026